2025-2026 Regular Session • US Congress Legislature
HB2542: Old Drugs, New Cures Act
Legislative Summary
To amend titles XVIII and XIX of the Social Security Act to provide that priority research drugs shall not be treated as line extensions of existing drugs for purposes of calculating manufacturer rebates under the Medicare and Medicaid programs, and for other purposes.
Bill History
4/1/2025
Introduced in House
House of Representatives
4/1/2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
House of Representatives
Status Information
Current Status
Introduced(4/1/2025)
Chamber
House of Representatives
Committee
Energy And Commerce(House of Representatives)
